Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.35 USD | -1.80% | -3.50% | +16.77% |
May. 31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
May. 31 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.77% | 2.06B | |
-4.22% | 12.45B | |
-0.60% | 8.22B | |
+6.61% | 5.72B | |
-10.21% | 4.11B | |
-60.35% | 2.68B | |
+10.62% | 2.68B | |
-5.50% | 2.37B | |
-9.18% | 1.8B | |
-2.30% | 1.6B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue